These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36351066)

  • 1. Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.
    Teixeira-Vaz A; Rocha JA; Reis DAE; Oliveira M; Moreira TS; Silva AI; Monteiro-Soares M; Paiva JA
    Rev Bras Ter Intensiva; 2022; 34(3):342-350. PubMed ID: 36351066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-associated Neurological Manifestations and Complications: An Observational Study.
    Rajendran B; N S; Ramkumar G
    J Assoc Physicians India; 2022 Dec; 70(12):11-12. PubMed ID: 37355967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.
    Frontera J; Mainali S; Fink EL; Robertson CL; Schober M; Ziai W; Menon D; Kochanek PM; Suarez JI; Helbok R; McNett M; Chou SH;
    Neurocrit Care; 2020 Aug; 33(1):25-34. PubMed ID: 32445105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.
    Villa RA
    Crit Care Sci; 2024; 36():e20240291en. PubMed ID: 38896725
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical characteristics of pediatric patients with acute respiratory distress syndrome due to COVID-19.
    Marroquín-Yáñez ML; Medeiros M; Chávez-López A; Carrillo-López HA; Soto-Bautista NP; Jarillo-Quijada AE; Gómez-Murillo SY; Láscari-Jiménez EC; Ruiz-Quiñones G; Barrera-Alonzo CJ; Contras-Santiago EM; Hernández-Hernández M
    Bol Med Hosp Infant Mex; 2022; 79(3):170-179. PubMed ID: 35882022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
    Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
    Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up.
    Nersesjan V; Amiri M; Lebech AM; Roed C; Mens H; Russell L; Fonsmark L; Berntsen M; Sigurdsson ST; Carlsen J; Langkilde AR; Martens P; Lund EL; Hansen K; Jespersen B; Folke MN; Meden P; Hejl AM; Wamberg C; Benros ME; Kondziella D
    J Neurol; 2021 Sep; 268(9):3086-3104. PubMed ID: 33438076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.
    Chou SH; Beghi E; Helbok R; Moro E; Sampson J; Altamirano V; Mainali S; Bassetti C; Suarez JI; McNett M;
    JAMA Netw Open; 2021 May; 4(5):e2112131. PubMed ID: 33974053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
    Javed A
    CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.
    Romoli M; Jelcic I; Bernard-Valnet R; García Azorín D; Mancinelli L; Akhvlediani T; Monaco S; Taba P; Sellner J;
    Eur J Neurol; 2020 Sep; 27(9):1712-1726. PubMed ID: 32503088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Intermittent Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome.
    Ramirez-Sandoval JC; Gaytan-Arocha JE; Xolalpa-Chávez P; Mejia-Vilet JM; Arvizu-Hernandez M; Rivero-Sigarroa E; Torruco-Sotelo C; Correa-Rotter R; Vega-Vega O
    Blood Purif; 2021; 50(3):355-363. PubMed ID: 33105136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical ventilation in COVID-19: A physiological perspective.
    Cronin JN; Camporota L; Formenti F
    Exp Physiol; 2022 Jul; 107(7):683-693. PubMed ID: 34541721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions.
    Beghi E; Giussani G; Westenberg E; Allegri R; Garcia-Azorin D; Guekht A; Frontera J; Kivipelto M; Mangialasche F; Mukaetova-Ladinska EB; Prasad K; Chowdhary N; Winkler AS
    J Neurol; 2022 May; 269(5):2265-2274. PubMed ID: 34674005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
    Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
    Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.